Annika J. Frank
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Histamine H3 receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 03, 2024
Aromatic linker variations in novel dopamine D2 and D3 receptor ligands.
Journal: Archiv der Pharmazie
Published: January 26, 2024
Discovery of a Small Molecule Activator of Slack (Kcnt1) Potassium Channels That Significantly Reduces Scratching in Mouse Models of Histamine-Independent and Chronic Itch.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 29, 2023
Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's Disease.
Journal: Molecules (Basel, Switzerland)
Published: November 23, 2022
Dual Targeting Ligands-Histamine H3 Receptor Ligands with Monoamine Oxidase B Inhibitory Activity-In Vitro and In Vivo Evaluation.
Journal: Pharmaceutics
Published: September 12, 2022
Cerclage performance analysis - a biomechanical comparison of different techniques and materials.
Journal: BMC musculoskeletal disorders
Published: February 04, 2022
Guanidine Derivatives: How Simple Structural Modification of Histamine H3R Antagonists Has Led to the Discovery of Potent Muscarinic M2R/M4R Antagonists.
Journal: ACS chemical neuroscience
Published: June 08, 2021
Biphenylalkoxyamine Derivatives-Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory Activity.
Journal: Molecules (Basel, Switzerland)
Published: May 19, 2021
Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's disease.
Journal: Bioorganic chemistry
Published: March 09, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H3 Receptor and Dopamine D2/D3 Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice.
Journal: International journal of molecular sciences
Published: January 20, 2021
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands.
Journal: Archiv der Pharmazie
Published: December 23, 2020
Variable Fixation Technology Provides Rigid as Well as Progressive Dynamic Fixation: A Biomechanical Investigation.
Journal: The Journal of bone and joint surgery. American volume
Published: October 21, 2020
Last Updated: 09/26/2026